Western blot analysis in patients with hypocaeruloplasminaemia

QJM: An International Journal of Medicine

Volumn 90, Issue 3, 1997, Pages 197-202

  Chowrimootoo, G F E ^a   Andoh, J ^a   Seymour, C A ^a  

^a ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CERULOPLASMIN; COPPER;

ADULT; AGED; ARTICLE; BILE; CERULOPLASMIN BLOOD LEVEL; CHRONIC ACTIVE HEPATITIS; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COPPER BLOOD LEVEL; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; IMMUNOBLOTTING; MALE; MENKES SYNDROME; PRIORITY JOURNAL; WILSON DISEASE;

EID: 0030903498     PISSN: 00335622     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/90.3.197     Document Type: Article

References (30)

1. Wilson SAK. Progressive lenticular degeneration. Brain 1912; 34:295-509.
2. Danks DM. Hereditary disorders of copper metabolism in Wilson's disease and Menkes disease. In: Stanbury JB, Wyngaarden JB, Frederickson DS, et al. (eds). The metabolic basis of inherited diseases, 5th edn. New York, McGraw-Hill, 1983:251-68.
3. Danks DM. Disorders of copper transport. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds). The metabolic and molecular basis of inherited disease, Vol 1, 7th edn. New York, McGraw-Hill, 1995: chapter 68; 2211-35.
4. Yarze JC, Martin P, Munoz SJ, Friedman LS. Wilson's disease: current status. Am J Med 1992; 92:643-54.
5. Walshe JM. Hudson Memorial Lecture: Genetics and biochemistry - their relevance to therapy. J Inherited Metab Dis 1983; 6 (Suppl.):51-8.
6. Saenko EL, Yaropolov AI, Harris ED. Biological functions of caeruloplasmin expressed through copper binding sites and a cellular receptor. J Trace Element Exp Med 1994; 7:69-88.
7. Chowrimootoo GFE, Seymour CA. New insight on to the pathogenesis of copper toxicosis in Wilson's disease. Biochem J 1996; 315:851-5.
8. Davis W, Chowrimootoo GFE, Seymour CA. Defective biliary copper excretion in Wilson's disease: the role of caeruloplasmin. Eur J Clin Invest 1996; 26:893-901.
9. Sternlieb I, Scheinberg IH. The role of radiocopper in the diagnosis of Wilson's disease. Gastroenterol 1979; 77:138-42.
10. Thomas GR, Forbes JR, Roberts EA, Walshe JM, Cox DW. The Wilson's disease gene: spectrum of mutations and their consequence. Nature Gen 1995; 9:210-17.
11. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage. Nature 1970; 227:680-5.
12. Henry RJ, Chiamoris N, Jacobs SL, Segalove M. Determination of caeruloplasmin oxidase in serum. Proc Soc Exp Med Biol 1960; 104:620-4.
13. Sternlieb I. Perspective in Wilson's disease. Hepatol 1990; 12:1234-9.
14. Sternlieb I, Scheinberg IH. Prevention of Wilson's disease in symptomatic patients. New Engl J Med 1968; 278:352-9.
15. McCullough AJ, Fleming CR, Thistle JL, Baldus WP, Ludwig J, McCall JT, Dickson ER. Diagnosis of Wilson's disease presenting as fulminant hepatitis. Gastroenterol 1983; 84:161-7.
16. Tankanow RM. Pathophysiology and treatment of Wilson's disease. Clin Pharmacy 1991; 10:839-49.
17. Gur H, Aderka D, Finkelstein A. Fulminant Wilsonian hepatitis: difficulties in diagnosis and treatment. Am J Gastroenterol 1988; 83:679-81.
18. Goldfischer S, Sternlieb I. Changes in the distribution of the hepatic copper in relation to progression of Wilson's disease (hepatolenticular degeneration). Am J Pathol 1968; 53:883-92.
19. Sternlieb I. Fraternal concordance of types of abnormal hepatocellular mitochrondria in Wilson's disease. Hepatol 1992; 16:728-32.
20. Walshe JM, Yealland M. Not Wilson's disease: a review of misdiagnosed cases. Q J Med 1995; 88:55-9.
21. Stremmel W, Meyerrose K-W, Niederau C, Hefter H, Kreuzpaintner G, Strohmeyer G. Wilson's disease: clinical presentation, treatment and survival. Ann Intern Med 1991; 115:720-6.
22. Starosta-Rubinstein S, Young AB, Kluin K, Hill G, Aisen AM, Gabrielson T, Brewer GJ. Clinical assessment of 31 patients with Wilson's disease. Arch Neurol 1987; 44:365-70.
23. Frommer D, Morris J, Sherlock S, Abrams J, Newman S. Kayser-Fleischer-like ring in patients without Wilson's disease. Gastroenterol 1977; 72:1331-5.
24. Ross ME, Jacobson IM, Dienstag JL, Martin JB. Late onset of Wilson's disease with neurological involvement in the absence of Kayser-Fleisher rings. Ann Neurol 1985; 17:411-13.
25. Walshe JM. Diagnosis and treatment of presymptomatic Wilson's disease. Lancet 1988; 2:435-7.
26. Case records of the Mass. General Hospital. Case 1 - 1997. N Engl J Med 1997; 336:118-25.
27. Frommer DJ. Urinary copper excretion and hepatic copper concentrations in liver disease. Digestion 1981; 21:169-78.
28. Gibbs K, Walshe JM. A study of the caeruloplasmin concentrations found in 75 patients with Wilson's disease, their kinships and various control groups. Q J Med 1979; 48:447-63.
29. Hiyamuta S, Shimizu K, Aoki T. Early diagnosis of Wilson's disease. Lancet 1993; 342:57-8.
30. Friedland JS, Remick DG, Shattock R, Griffin GE. Secretion of interleukin-8 following phagocytosis of mycobacterium tuberculosis by human monocytes cell lines. Eur J Immunol 1992; 22:1373-8.